Psychedelics Investing GreenStar Biosciences Completes Acquisition of 100 Percent of Eleusian Biosciences Corp. and Appoints Jonathan Gilbert to Board of Directors and Maghsoud Dariani as Chief Science Officer
Psychedelics Investing GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences
Pharmaceutical Investing Greenstar Biosciences Signs Agreement to Acquire 100 Percent of Eleusian Biosciences Corp.
Brunswick Exploration Announces Brokered Private Placement for Gross Proceeds of up to C$2.5 Million, with a Lead Order from a Strategic Investor
RETRANSMISSION: Group Eleven to be Featured on Radius Research for a Live Company Pitch, Deep Dive and Q&A Webinar
